Elaine Butterly

Jun 24, 2024 | medrxiv.org | Peter Hanlon |Elaine Butterly |Lili Wei |Heather Wightman

John Petrie reports personal fees (via his employing institution) from Merck KGaA (Lectures), research support from Merck KGaA (Grant), personal fees from Novo Nordisk (Lectures/ Advisory) and personal fees from IQVIA (Boehringer Ingelheim Adjudication Committees) - all outside the submitted work.

Jun 6, 2023 | journals.plos.org | Peter Hanlon |Elaine Butterly |Laurie J. Hannigan |Anoop SV Shah

Loading metrics Open Access Peer-reviewedResearch Article AbstractBackgroundPeople with comorbidities are underrepresented in clinical trials. Empirical estimates of treatment effect modification by comorbidity are lacking, leading to uncertainty in treatment recommendations. We aimed to produce estimates of treatment effect modification by comorbidity using individual participant data (IPD).